WOLFGANG WINKELMAYER to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Angiotensin Receptor Antagonists.
Connection Strength
2.443
-
Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study. BMC Nephrol. 2017 Jun 17; 18(1):196.
Score: 0.524
-
Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis. Nephrol Dial Transplant. 2017 May 01; 32(5):862-869.
Score: 0.520
-
Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis. J Nephrol. 2017 Apr; 30(2):281-288.
Score: 0.493
-
Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors. Int J Cardiol. 2008 Apr 10; 125(2):172-7.
Score: 0.269
-
Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing? Health Aff (Millwood). 2007 May-Jun; 26(3):800-7.
Score: 0.260
-
Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease. Nephrol Dial Transplant. 2021 09 27; 36(10):1893-1899.
Score: 0.176
-
Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors: challenges in comparative effectiveness using Medicare data. Clin Pharmacol Ther. 2011 May; 89(5):674-82.
Score: 0.085
-
Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J Am Soc Nephrol. 2011 Apr; 6(4):864-9.
Score: 0.084
-
Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis. Clin J Am Soc Nephrol. 2016 08 08; 11(8):1401-1412.
Score: 0.031